PTC Inc header image

PTC Inc

PTC

Equity

ISIN null / Valor 20488241

NASDAQ (2025-11-17)
USD 174.21-3.01%

PTC Inc
UMushroom community rating:

star star star star star
3.00 1 votes No rating yet
NegativeNeutralPositive

About company

PTC Inc is a global software company that specializes in providing technology solutions for product development, manufacturing, and service. Their offerings include software for computer-aided design, product lifecycle management, and Internet of Things connectivity.

Summarized from source with an LLMView SourceSector: Technology

Latest Results (26.10.2025):

PTC Inc reported strong financial performance for the third fiscal quarter of 2025, demonstrating solid execution and growth across key metrics. The company exceeded its guidance in several areas, including Annual Recurring Revenue (ARR), operating cash flow, and free cash flow, while also raising its outlook for the full fiscal year.

Annual Recurring Revenue (ARR) Growth

PTC Inc achieved a constant currency ARR growth of 9.3% in Q3'25, placing it at the higher end of the company's guidance range. This growth reflects the company's effective strategy in expanding its product data foundations and enhancing value across various industries and regions.

Operating and Free Cash Flow

Both operating cash flow and free cash flow grew by 14% year-over-year, surpassing the guidance ranges. This robust cash flow performance was driven by strong ARR growth, a subscription-based business model, and disciplined financial management.

Revenue Growth

Revenue for Q3'25 increased by 24% year-over-year to $644 million, significantly exceeding the previous year's $519 million. This growth underscores PTC Inc's successful market expansion and product offerings.

Updated Financial Guidance

PTC Inc has raised its full-year 2025 guidance for ARR, free cash flow, revenue, earnings per share (EPS), and non-GAAP EPS. The company now expects approximately $850 million in free cash flow for FY'25 and continued ARR growth in the range of 8% to 9%.

Share Repurchases

Continuing its commitment to returning value to shareholders, PTC Inc proceeded with share repurchases under its $2 billion authorization. The company repurchased $75 million worth of its stock in Q3'25 and plans an additional $75 million in Q4'25, aiming to complete a total of $300 million for the fiscal year.

Strategic Focus on AI and Vertical Growth

PTC Inc is advancing its foundation for AI-driven and verticalized growth, positioning itself for long-term success. The company continues to enhance its offerings across CAD, PLM, ALM, SLM, and SaaS, driving key customer wins and expanding its market presence.

Summarized from source with an LLMView Source

Key figures

-8.32%1Y
40.6%3Y
75.7%5Y

Performance

32.7%1Y
25.9%3Y
31.4%5Y

Volatility

Market cap

20869 M

Market cap (USD)

Daily traded volume (Shares)

847,726

Daily traded volume (Shares)

1 day high/low

184.255 / 181.56

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

3.00

1 votes
Performance:
starstarstarstarstar
4.00
Innovation:
starstarstarstarstar
3.00
Society:
starstarstarstarstar
3.00
Nature:
starstarstarstarstar
3.00
Tej Ram Kumpakha
Switzerland, 30 Mar 2022
star star star star star
The company do have impressive positive financial results but the recent trading volume jumps may be little concerning for the share price.

EQUITIES OF THE SAME SECTOR

Pegasystems Inc
Pegasystems Inc Pegasystems Inc Valor: 503997
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-3.87%USD 54.65
Halozyme Therapeutics Inc
Halozyme Therapeutics Inc Halozyme Therapeutics Inc Valor: 1814799
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.76%USD 70.56
Tarsus Pharmaceuticals Inc
Tarsus Pharmaceuticals Inc Tarsus Pharmaceuticals Inc Valor: 57410241
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.71%USD 74.17
Flywire Corp
Flywire Corp Flywire Corp Valor: 111444572
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.51%USD 13.57
Sezzle Inc
Sezzle Inc Sezzle Inc Valor: 129105133
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.24%USD 50.97
PAR Technology Corporation
PAR Technology Corporation PAR Technology Corporation Valor: 960461
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-5.66%USD 36.70
Toast Inc
Toast Inc Toast Inc Valor: 113470913
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-3.31%USD 34.71
Sportradar Group AG
Sportradar Group AG Sportradar Group AG Valor: 113423966
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.33%USD 21.81
Duolingo Inc
Duolingo Inc Duolingo Inc Valor: 112404331
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-3.67%USD 178.27
STEMMER IMAGING AG
STEMMER IMAGING AG STEMMER IMAGING AG Valor: 40430134
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.00%EUR 59.00